GARY CLARK to Anticonvulsants
This is a "connection" page, showing publications GARY CLARK has written about Anticonvulsants.
Connection Strength
0.668
-
Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program. Epilepsia Open. 2024 Oct; 9(5):1816-1825.
Score: 0.180
-
Add-on Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex: A Placebo-Controlled Randomized Clinical Trial. JAMA Neurol. 2021 03 01; 78(3):285-292.
Score: 0.142
-
Open-label use of highly purified CBD (Epidiolex?) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes. Epilepsy Behav. 2018 09; 86:131-137.
Score: 0.118
-
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome. N Engl J Med. 2018 May 17; 378(20):1888-1897.
Score: 0.117
-
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017 05 25; 376(21):2011-2020.
Score: 0.110